Acute Myeloid Leukemia Market to Reach USD 4.72 Billion by 2030, Driven by Precision-Targeted Drugs and Asia‐Pacific Growth

Mordor Intelligence has published a new report on the Acute Myeloid Leukemia Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The global Acute Myeloid Leukemia (AML) Market is expected to grow from USD 2.88 billion in 2025 to USD 4.72 billion by 2030, reflecting a compound annual growth rate (CAGR) of 10.42% over the period. This growth is underpinned by an ageing population, the rise of mutation-driven leukemia cases, and the introduction of precision medicines targeting genetic drivers like FLT3, IDH1/2, and BCL‐2.

Report Overview: https://www.mordorintelligence.com/industry-reports/acute-myeloid-leukemia-therapeutics-market?utm_source=openpr

Key Trends

Focus on Molecularly Targeted Therapise
Clinical practice is shifting away from broad chemotherapy and toward targeted therapies guided by molecular profiling. Drugs that address mutations such as FLT3, IDH1/2, BCL‐2, and menin are gaining ground as frontline and combination strategies.

Rapid Growth of Immunotherapy
Immunotherapy-such as CAR‐T cells and antibody‐drug conjugates-is growing faster than other categories. These therapies offer durable responses and are being tested across high-risk and relapsed AML populations.

Wider Use of Genetic Testing and Diagnostics
Advances in next-generation sequencing are expanding diagnostic capabilities, enabling precise mutation identification and personalized treatment decisions. This diagnostic refinement is increasing the treatable population.

Market Segmentation

By Therapy Class

Chemotherapy

Targeted Therapy

Immunotherapy (incl. CAR-T, bispecifics)

Stem-cell Transplant

Supportive / Others

By Mechanism / Molecular Target

FLT3 Inhibitors

IDH1/2 Inhibitors

BCL-2 Inhibitors

Hedgehog Pathway Inhibitors

CD33-Directed Antibody-Drug Conjugates

By Geography:

North America

Europe

Asia‐Pacific

South America

Middle East & Africa

Key Players

Leading global companies operating in the Acute Myeloid Leukemia Market include:

Pfizer Inc.

Novartis AG

Bristol Myers Squibb

Astellas Pharma

AbbVie

Conclusion

Chemotherapy remains foundational, but its dominance is gradually challenged by targeted therapies and immunotherapies that offer better tolerability and outcomes, particularly for older patients. North America continues to lead in revenue, while Asia-Pacific stands out as the fastest-growing region due to therapeutic access and public health developments.

Industry Related Reports

Asia-Pacific Acute Myeloid Leukemia Treatment Market: Asia-Pacific Acute Myeloid Leukemia Treatment Market is Segmented by Therapy (Chemotherapy, Targeted Therapy, Stem Cell Transplant, and Other Therapies) and Geography (China, Japan, India, Australia, South Korea, and the Rest of Asia-Pacific).

Get More Insights: https://www.mordorintelligence.com/industry-reports/asia-pacific-acute-myeloid-leukemia-treatment-market?utm_source=openpr



Leukemia Therapeutics Market: The Leukemia Therapeutics Market Report is Segmented by Treatment Type (Chemotherapy, Immunotherapy, and More), Leukemia Type (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, and More), Therapy Modality (Small-Molecule Drugs, Monoclonal Antibodies and More), Rpute of Administration(Oral, Intravenous and More), Age Group (Pediatric, Adults and More) and Geography.

Get More Insights: https://www.mordorintelligence.com/industry-reports/global-leukemia-therapeutics-market-industry?utm_source=openpr



Interferons Market: The Interferons Market Report is Segmented by Product Type (Interferon Alpha, Interferon Beta, and Interferon Gamma), Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, and Renal Cell Carcinoma), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Get More Insights: https://www.mordorintelligence.com/industry-reports/interferons-market?utm_source=openpr

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.